Introduction {#s01}
============

Controlled release of neurotransmitters and hormones from secretory cells occurs through the process of exocytosis. Exocytosis is triggered by a rise in intracellular Ca^2+^ ([@bib62]; [@bib119]; [@bib12]), with members of the synaptotagmin (Syt) protein family acting as the Ca^2+^ sensors that trigger vesicle-to-plasma-membrane fusion ([@bib30]). Synaptotagmins interact with soluble *N*-ethyl maleimide--sensitive factor attachment protein receptor (SNARE) proteins, which constitute the core membrane fusion machinery, as well as anionic phospholipid membranes, as part of the mechanism used to couple Ca^2+^ binding to opening of the fusion pore ([@bib196]; [@bib36]; [@bib202]; [@bib200]). There are 17 different isoforms of synaptotagmin present in mammals, 8 of which trigger membrane fusion in response to Ca^2+^ over a range of affinities and with different activation kinetics ([@bib27]; [@bib91]; [@bib52]; [@bib153]). A growing number of studies are revealing how different synaptotagmin isoforms exert characteristic effects on the rate and extent of exocytosis, and how synaptotagmin diversity may permit multilayered modulation of content release through isoform-specific effects on fusion dynamics ([@bib185]; [@bib253]; [@bib174], [@bib175]). This review focuses on Syt-7, a high-affinity Ca^2+^ sensor that has been implicated in regulating exocytosis across a wide range of cellular and physiological contexts.

The synaptotagmins share a common molecular architecture comprising an N-terminal transmembrane domain that anchors the protein to lipid bilayers, a linker region, and tandem cytoplasmic Ca^2+^ binding domains, termed C2A and C2B ([@bib201]). Synaptotagmin isoforms possess a range of Ca^2+^ affinities, with some exhibiting no detectable Ca^2+^ binding ([@bib228]; [@bib25]; [@bib107]; [@bib236]). The C2A and C2B domains interact with multiple effectors in Ca^2+^-independent and -dependent ways. Notable interaction partners include the t-SNAREs, syntaxin and SNAP-23/25, on the plasma membrane ([@bib173]; [@bib26]; [@bib252]; [@bib237]; [@bib258]). Additionally, the C2 domains of synaptotagmins bind membranes containing anionic phospholipids such as phosphatidylserine (PS) and phosphatidylinositol-(4,5)-bisphosphate ([@bib55]; [@bib37]; [@bib184]; [@bib143], [@bib144]; [@bib198]; [@bib229]; [@bib165]; [@bib218]). Binding of Ca^2+^ to the C2 domains prompts their insertion into lipid bilayers. The interaction of synaptotagmin, Ca^2+^, and anionic phospholipids is thought to play a key role in stimulus-secretion coupling ([@bib207]; [@bib18]; [@bib108]). Among the known synaptotagmin isoforms, Syt-7 has the highest Ca^2+^ sensitivity, capable of binding anionic phospholipids and stimulating membrane fusion in vitro at Ca^2+^ concentrations \<1 µM ([@bib206]; [@bib25]).

Studies of exocytosis using optical imaging techniques and electrophysiological measurements have provided many examples of how different synaptotagmin isoforms confer distinct effects on exocytosis dynamics by affecting the probability, extent, and rate of content release, as well as determining the choice among alternate fusion modes ([@bib253]; [@bib174], [@bib175]). The large variety of synaptotagmin isoforms present in mammalian cells, combined with coexpression of multiple isoforms within the same cell, suggests the potential for fine tuning of secretory outputs in response to different stimuli or physiological circumstances.

Historically, the most widely studied synaptotagmin isoform has been Syt-1, which triggers fast, synchronous neurotransmitter release in neurons and neuroendocrine cells ([@bib85]). Although the intent of this review is to focus on the properties and activities of Syt-7, reference will occasionally be made to mechanistic studies performed using Syt-1, to the extent that they highlight features that can reasonably be assumed to be shared among synaptotagmin family members. Additionally, it will often prove instructive to compare and contrast Syt-1 and Syt-7 activities to draw attention to what makes Syt-7 stand apart. In many cases, the functions attributed to Syt-7 occur in cells coexpressing Syt-1 (or the closely related Syt-2 or Syt-9 isoforms), and indeed, it is often the juxtaposition of their competing activities that gives rise to the observed effects ([@bib239]; [@bib13]; [@bib174]; [@bib141]). Therefore, an appreciation of the differences between Syt-7 and other isoforms---especially with respect to biochemistry and structure---is necessary for understanding how regulatory functions attributed to Syt-7 become manifest. Syt-7, by dint of the high Ca^2+^-dependent phospholipid affinity of its C2 domains, is well suited for processes operating at low intracellular Ca^2+^. As is discussed in this review, such properties provide a mechanistic framework for understanding Syt-7's actions at synapses, in neuroendocrine tissue, and within a variety of other cellular contexts.

Diverse cellular functions of Syt-7 {#s02}
===================================

Syt-7 has been shown to act as the Ca^2+^ sensor for regulated exocytosis in a variety of cellular contexts ([Table 1](#tbl1){ref-type="table"}). Expression of Syt-7 is widespread in mammals ([Fig. 1](#fig1){ref-type="fig"}). Despite its ubiquitous expression, Syt-7 knockout (KO) mice are viable into adulthood ([@bib149]). Thus, it is very likely that another isoform compensates for Syt-7's essential functions.

###### Syt-7 expression and function in various mammalian cells

  Cell type                              Function                                                                         Reference
  -------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------
  Acinar cells, pancreas                 Not characterized                                                                [@bib66]
  Acinar cells, parotid                  Not characterized                                                                [@bib116]
  Adipocytes                             Glucose uptake                                                                   [@bib134]
  Alveolar type II cells, lung           Lamellar body exocytosis                                                         [@bib159]
  Cardiac sympathetic nerve terminals    Neuroepinephrine secretion                                                       [@bib192]
  Chromaffin/PC12 cells                  Stress hormone secretion                                                         [@bib77]; [@bib185]; [@bib253]; [@bib174]
  Fibroblasts                            Lysosomal exocytosis and membrane repair                                         [@bib149]; [@bib176]; [@bib33]
  Melanotrophs, intermediate pituitary   Not characterized                                                                [@bib122]
  Macrophages                            Phagocytosis                                                                     [@bib22]
                                         Migration                                                                        [@bib168]
  Neurons                                Asynchronous release (although also see [@bib246]; [@bib245] for role of Doc2)   [@bib13]; [@bib237]; [@bib142]; [@bib214]
                                         Synaptic facilitation                                                            [@bib40]; [@bib111]; [@bib214]
  Osteoclasts and osteoblasts            Bone remodeling                                                                  [@bib254]
  α Cells, pancreas                      Glucagon secretion                                                               [@bib93]
  β Cells, pancreas                      Insulin secretion                                                                [@bib134]; [@bib92]; [@bib60]
  T-cell lymphocyte                      Cytolytic T cell responses                                                       [@bib70]

![**Syt-7 RNA-seq results from 27 human tissues.** Quantitative transcriptomic analysis (RNA-seq) of Syt-7 was performed using NCBI (<https://www.ncbi.nlm.nih.gov/gene/9066/?report=expression>) with data obtained from [@bib65], BioProject PRJEB4337, and BioProject PRJEB4337. The relative expression levels are shown in reads per kilobase per million reads placed (RPKM). RPKM is a normalized unit of specific gene transcription. Genes in different tissues were screened and scored based on total RNA level. The scores are normalized to 1 million reads (per million reads placed) to correct for the transcription activity differences in various tissues. The "per million reads placed" scores are divided by the length of the gene (per kilobase). Error bars represent SD.](JGP_201711944_Fig1){#fig1}

One of the first characterized cellular functions for Syt-7 was in Ca^2+^-dependent lysosomal exocytosis ([@bib149]). During this process, lysosomes fuse with the plasma membrane, providing a means to repair tears or breaks in the membrane after damage ([@bib149]; [@bib176]). Lysosomal exocytosis, mediated by Syt-7, is also responsible for supplying excess membrane and releasing bone-degrading molecules at the ruffled border of osteoclasts, which resorb old bone during healing and repair ([@bib254]). Bone maintenance, remodeling, and repair further depend on secretion of bone matrix proteins from osteoblasts, a process that is mediated by Syt-7 present on secretory vesicles. These functions are compromised in Syt-7 KO mice, which have reduced bone volume and are susceptible to osteoporosis ([@bib254]). Syt-7--dependent delivery of excess membrane to the cell surface through lysosome exocytosis also figures prominently in neurite outgrowth ([@bib10]) and the ability of macrophages to engulf and take up foreign particles for phagocytic degradation ([@bib53]; [@bib22]).

A key role has also been identified for Syt-7 in regulating Ca^2+^-dependent exocytotic events that contribute to maintenance of glucose homeostasis. Syt-7 positively regulates Ca^2+^-stimulated secretion of insulin from large dense-core vesicles in pancreatic β cells ([@bib92]) and Ca^2+^-stimulated release of glucagon from vesicles in pancreatic α-cells ([@bib93]). In adipocytes and skeletal muscle cells, Syt-7 promotes incorporation of the GLUT4 glucose transporter into the plasma membrane ([@bib134]). Disruption of these processes in Syt-7 KO mice results in glucose intolerance ([@bib134]; [@bib92]). A decrease in glucose-stimulated insulin secretion was also observed after knockdown of Syt-7 in human pancreatic β cells ([@bib60]).

Ca^2+^-triggered secretion of vesicle contents depends on Syt-7 in other specialized settings, including release of norepinephrine from cardiac sympathetic nerve terminals ([@bib192]) and release of lytic enzymes from T-cell lymphocytes that destroy target cells ([@bib70]). The fact that Syt-7 regulates exocytosis in all of these different contexts may indicate a requirement for exocytosis to be activated efficiently by small increases in intracellular Ca^2+^, for which Syt-7 is particularly well suited given its high Ca^2+^ sensitivity ([@bib206]). Although Syt-7 was identified as a key player in controlling the Ca^2+^-dependent membrane fusion events described above, it may function jointly with other isoforms in mediating exocytosis in these instances. For example, insulin secretion is decreased by only ∼40% in Syt-7 KO mice, suggesting that other Ca^2+^ sensors---such as Syt-9, which is expressed at comparable levels in pancreatic islets---are likely involved ([@bib92]; [@bib91]). Syt-7 was identified as the principal Ca^2+^ sensor behind nearly all glucagon secretion from α-cells, but this appears to be the exception rather than the rule ([@bib93]).

In several cell types, the interplay between the activities of Syt-7 and other synaptotagmin isoforms has been studied to some extent. Syt-7 is highly and ubiquitously expressed in the brain ([Fig. 1](#fig1){ref-type="fig"}), where it is commonly found with one or more of the lower-affinity isoforms Syt-1, 2, and/or 9 ([@bib132], [@bib135]; [@bib217]; [@bib239]; [@bib13], [@bib14]; [@bib153]; [@bib142]). The juxtaposition of these isoforms with Syt-7 may allow for modulation of the secretory response as a function of spatial and temporal variations in the Ca^2+^ signal and can have interesting physiological consequences ([@bib239]; [@bib13], [@bib14]; [@bib142]; [@bib135]; [@bib141]). It has been hypothesized that combination of synaptotagmins with different Ca^2+^ sensitivities could afford a range of possibilities for fusion output, based on differential activation of synaptotagmin isoforms according to the strengths or patterns of stimulation in excitable cells ([@bib153]).

Syt-7, via interactions with effector proteins, could also regulate exocytosis upstream of the fusion event. Loss of Syt-7 activity in KO cells causes a reduction of sustained release during stimulus trains, which was suggested to result from a role of Syt-7 in replenishment of the readily releasable vesicle pool ([@bib137]). The effect of Syt-7 removal was recapitulated by loss of calmodulin, and Syt-7 was found to associate tightly with calmodulin in a manner that depended on Ca^2+^ binding to its C2 domains. These data suggest that the Syt-7--calmodulin complex plays a fundamental role in regulating vesicle replenishment at synapses ([@bib137]).

Syt-1 and Syt-7 are the major synaptotagmin isoforms present in adrenal chromaffin cells ([@bib152]; [@bib185]; [@bib150]). Chromaffin cells secrete a cocktail of bioactive agents into the bloodstream in response to sympathetic activation ([@bib32]). Strong stimulation of secretion from chromaffin cells has revealed rapid and delayed exocytotic components ([@bib98], [@bib99]; [@bib49]), with the initial fast phase corresponding to release from the readily releasable pool (RRP) and a delayed release component from the slowly releasable pool (SRP) of vesicles ([@bib197]; [@bib185]). Membrane capacitance measurements combined with Ca^2+^ uncaging in Syt-1 KO mice showed that the rapid phase of release is eliminated in the absence of Syt-1 ([@bib226]; [@bib185]). The remaining delayed component exhibits a Ca^2+^ threshold that closely mirrors the low, micromolar-range sensitivity of Syt-7 for binding to phospholipids in the presence of Ca^2+^ ([@bib206]). Furthermore, deletion of Syt-7 in a Syt-1 KO background almost completely eliminates the slow phase of release ([@bib185]). Syt-7 has been hypothesized to affect exocytosis kinetics either by interacting with and modulating the release rate of Syt-1--containing vesicles ([@bib185]; [@bib237]) or by triggering fusion of a subpopulation of predominantly Syt-7--containing vesicles ([@bib174]). In either case, the combination of Syt-1 and Syt-7 could permit fine-tuning of secretory outputs. For example, the ability of Syt-7 to promote fusion at much lower Ca^2+^ concentrations may provide the basis for constitutive release of neurotransmitters in response to low-level, basal stimulation ([@bib79]).

Intracellular localization of Syt-7 {#s03}
===================================

The fact that Syt-7 regulates exocytosis in such a wide array of cellular contexts raises the question of whether it imparts control over fusion through a common mechanism in all cases, or whether different functional modes are exploited in different circumstances. One piece of information that seems necessary for answering this question is the subcellular localization of Syt-7. In neurons, based on immunostaining of endogenous Syt-7 combined with light and electron microscopy, Syt-7 was found close to presynaptic active zones but did not appear to overlap with clusters of vesicles ([@bib205]). Thus, it was concluded that Syt-7 is bound to the plasma membrane, an interpretation further supported by subcellular fractionation measurements ([@bib205]). Other studies have subsequently reported a plasma membrane localization of Syt-7 in neurons ([@bib225]; [@bib237]; [@bib112]).

These results stand in sharp contrast with studies indicating that Syt-7 is targeted primarily to internal organelles, including large dense-core vesicles in both primary and immortalized neuroendocrine cells ([@bib76], [@bib77]; [@bib236]; [@bib211]; [@bib253]; [@bib174], [@bib175]; [@bib60]) and lysosomes in nonneuronal cells ([@bib149]; [@bib176]). One such study performed quantitative immunostaining of tag-free, up-regulated Syt-7 in PC12 cells and found significant colocalization of Syt-7 with vesicle and lysosome markers but minimal overlap with the plasma membrane marker syntaxin-1a ([@bib236]; [Fig. 2](#fig2){ref-type="fig"}). Similarly, numerous studies have localized GFP-tagged Syt-7 to the surface of large dense-core vesicles in PC12 cells and chromaffin cells ([@bib77]; [@bib253]; [@bib174], [@bib175]; [@bib23]). Thus, there is considerable evidence that in neuroendocrine cells Syt-7 does not act as a plasma membrane Ca^2+^ sensor but instead regulates exocytosis directly from the vesicle surface, perhaps acting similarly to Syt-1 but with a different Ca^2+^ sensitivity.

![**Syt-7 is predominantly localized on large dense-core vesicles and lysosomes in PC12 cells. (A)** Syt-7--expressing (green) PC12 cells show low colocalization with a plasma membrane marker, syntaxin 1A (red). **(B)** Representative immunofluorescence images of Syt-7 and the vesicular protein, chromogranin B (Cg, first row), or the lysosomal protein, Lamp1 (second row). **(C)** Graphical representation of A. **(D)** Graphical representation of B, demonstrating significant colocalization of Syt-7 with organelle markers. Adapted with permission from [@bib236]. Error bars are ±SEM.](JGP_201711944_Fig2){#fig2}

[@bib236] found a significant degree of overlap between Syt-7 and Syt-1 in PC12 cells, suggesting that multiple synaptotagmin isoforms can reside on the same secretory vesicle. The divalent metal dependence of catecholamine release in these cells was sensitive to Syt-7 expression level; dose--response curves shifted to lower concentrations when Syt-7 was overexpressed and to higher concentrations when Syt-7 expression was knocked down with RNAi. This correlation suggests that the ratio of Syt-7 to Syt-1 on each vesicle dictates the metal sensitivity of release ([@bib236]). Other studies using fluorophore-tagged synaptotagmin constructs found that Syt-1 and Syt-7 were largely sorted to separate vesicle populations, indicating that different vesicle pools may be endowed with distinct fusion properties via selective isoform sorting ([@bib174]). Colocalization studies of Syt-1, 4, 7, and 9 in PC12 and primary rat chromaffin cells suggested that vesicles can harbor multiple synaptotagmin isoforms ([@bib150]). In PC12s, Syt-1 and Syt-7 have lower colocalization (∼45%) than other isoform pairs. Partial spatial segregation of Syt-1 and Syt-7 could be achieved through differential sorting based on vesicle size, with Syt-1 and Syt-7 showing preference for smaller and larger vesicles, respectively ([@bib253]). This size preference was also noted in primary rat chromaffin cells ([@bib150]).

The presence of Syt-7 on the plasma membrane versus secretory vesicles, and the degree of cosorting with other synaptotagmin isoforms, could be influenced by a variety of factors. Intracellular trafficking could be affected by experimental variables such as fluorescent protein tags and their placement and/or higher-than-normal protein expression levels causing spillover to nonphysiological sites. Although we have consistently observed overexpressed Syt-7 to have a predominantly vesicular localization ([@bib174]), the relative abundance of protein on the plasma membrane of bovine chromaffin cells is variable from cell preparation to preparation. The balance of its localization may be affected by overexpression, which in turn, has the potential to alter the balance of anterograde and retrograde trafficking reactions within a cell. It is also possible that physiologically relevant differences in Syt-7 trafficking occur according to cell type or context that allow targeting of Syt-7 activity to a specific subcellular location or regulation of its mode of action.

Posttranslational protein modifications may affect the intracellular trafficking of synaptotagmins ([@bib38]; [@bib221]; [@bib72]; [@bib97]; [@bib95]; [@bib117]; [@bib118]; [@bib69]; [@bib127]). In one study, *N*-glycosylation was shown to play a critical role in proper targeting of Syt-1 to vesicles in both neurons and PC12 cells ([@bib95]). A point mutation (N24Q) that abolished *N*-glycosylation altered Syt-1 localization from PC12 secretory vesicles to the plasma membrane. Surprisingly, in Syt-1 KO neurons expressing the glycosylation mutant, synchronous release was restored despite the protein being missorted ([@bib95]). A different study showed that vesicular sorting of Syt-1 *N*- and *O*-glycosylation mutants was disrupted only when proteins were expressed in a wild-type rather than Syt-1 KO background ([@bib127]). Thus, glycosylation's role in proper Syt-1 sorting, and thereby synaptic function, may be context dependent.

Syt-7 also undergoes several posttranslational modifications in the cell. Three cysteine residues located within and adjacent to the Syt-7 transmembrane domain are palmitoylated, and palmitoylation was shown to be necessary for targeting of Syt-7 to lysosomes ([@bib69]). Potentiation of insulin secretion requires phosphorylation of Syt-7 at Ser103 by protein kinase A, and Syt-7 is likely to be phosphorylated at other sites as well ([@bib242]). Whether posttranslational modifications could account for some of the apparent discrepancies in the literature with respect to Syt-7 localization remains to be determined.

Context-dependent effects of Syt-7 could also be related to alternative splicing. The standard form of Syt-7 is 403 amino acids long, with a molecular weight of ∼45 kD ([@bib91]). However, multiple Syt-7 protein variants resulting from alternative splicing of the Syt-7 gene primary transcript have been identified. These variants exhibit temporally and spatially regulated patterns of expression during development ([@bib205]). In rat brain, at least 12 variants have been identified that range in size from 122 to 687 amino acids; some are truncated versions missing the C2 domains, whereas others harbor extended linker regions ([@bib205]). Truncated and extended isoforms were found to have competing effects on synaptic vesicle recycling in rat hippocampal neurons, in that recycling was enhanced by a truncated isoform and decelerated by an extended-linker isoform ([@bib225]). In mouse brain, three isoforms have been identified: the dominant canonical isoform, Syt-7α, and two alternate isoforms, Syt-7β and Syt-7γ, whose spacer regions contain insertion sequences of 44 and 116 amino acids, respectively ([@bib76]). Similarly, pancreatic β-cells have been found to express the α, β, and δ isoforms of Syt-7; the δ isoform is a truncated version that localized to a different vesicle population and inhibited insulin secretion upon overexpression in INS-1E cells ([@bib84]). The functional differences among isoforms with different linker lengths are not yet well understood.

The role of Syt-7 in synaptic transmission {#s04}
==========================================

Although Syt-7 is expressed in nonneural tissues, it is particularly enriched in the brain ([@bib132]). Syt-7's prominent neuronal expression and high Ca^2+^ affinity immediately led to suggestions that in neurons Syt-7 could serve as a specialized high-affinity sensor to support two forms of presynaptic plasticity that are driven by submicromolar Ca^2+^ signals: asynchronous release and facilitation ([@bib260]; [@bib261]; [@bib107]).

Asynchronous release refers to the delayed, slow release of neurotransmitter that persists after the end of a single action potential or a train of action potentials. The term originates from early descriptions of evoked release at the frog neuromuscular junction (NMJ; [@bib21]; [@bib87]). These classic electrophysiological studies demonstrated the possibility of separable Ca^2+^-dependent release mechanisms based on the fact that exocytosis followed multiple, kinetically distinguishable rates ([@bib87]). Facilitation involves the transient elevation of release probability after an action potential, which can drastically increase the amount of neurotransmitter released if a second action potential arrives shortly after the first ([@bib111]). Because facilitation and asynchronous release both rely on the same submicromolar Ca^2+^ signal, reflect a transient increase in release probability, and exhibit similar decay kinetics, it was suggested early on that they might use the same mechanism ([@bib172]).

Action potentials cause brief, large Ca^2+^ signals in the immediate vicinity of open voltage-gated Ca^2+^ channels ([@bib139]; [@bib11]; [@bib250]). These "nanodomains" of Ca^2+^ are thought to reach tens or hundreds of micromolar ([@bib194]), which would activate low-affinity Ca^2+^ sensors such as Syt-1 and Syt-2 to drive synchronous vesicle fusion and neurotransmitter release. Nanodomains quickly collapse at the end of an action potential when voltage-gated Ca^2+^ channels close, after which a modest amount of residual free Ca^2+^ persists in the presynaptic terminal before being buffered by endogenous Ca^2+^-binding proteins, sequestered into intracellular organelles, or extruded ([@bib50]; [@bib261]). It is in the context of this "residual Ca*^2+^* hypothesis" that the role of Syt-7 might be best understood, where it acts as a high-affinity sensor to detect modest Ca^2+^ signals and increase vesicle release probability ([@bib120]; [@bib111]).

Early studies {#s05}
-------------

Early studies of neuronal synapses detected no discernible effect of Syt-7 on synaptic transmission. At the *Drosophila melanogaster* larval NMJ, knockdown of Syt-7 caused no change in either the initial release probability or short-term plasticity ([@bib183]). Similarly, at inhibitory synapses between cultured mouse cortical neurons, Syt-7 KO had no effect on baseline release, short-term plasticity, or delayed release after train stimulation (asynchronous release; [@bib152]). These results are somewhat surprising and difficult to explain, given that subsequent studies found that Syt-7 plays a role in both facilitation and asynchronous release. However, in the case of the *D*. *melanogaster* NMJ, an earlier study failed to detect presynaptic Syt-7 in wild-type animals, which may explain why Syt-7 knockdown did not change the properties of synaptic transmission ([@bib1]). Similarly, it is not known whether Syt-7 is normally present at inhibitory synapses in cortical cultures. Moreover, cultured neurons often fail to exhibit normal short-term plasticity, possibly because cultured neurons fail to develop the normal complement of synaptic proteins and/or because cultured neurons are often studied using nonphysiological extracellular Ca^2+^ concentrations.

Asynchronous release {#s06}
--------------------

The first indication that Syt-7 plays a role in synaptic transmission came from the zebrafish NMJ, where knockdown of Syt-7 led to a marked decrease in asynchronous release ([@bib239]). At the zebrafish NMJ, prolonged train stimulation results in two separate forms of release. Early in the train, release is synchronized to each action potential. Later in the train, release becomes less synchronized, and more release events occur in between action potentials. Knockdown of Syt-7 left synchronous release intact but abolished asynchronous release. Knockdown of Syt-2 (the dominant low-affinity synaptotagmin isoform at this synapse) had the opposite effect, preserving asynchronous release while abolishing the early synchronous component. Thus at the zebrafish NMJ, these two synaptotagmin isoforms mediate kinetically distinguishable forms of neurotransmitter release.

Syt-7's role in asynchronous release has been subsequently proposed at many other synapses. These include cultured hippocampal neurons ([@bib13]; [@bib135]), excitatory synapses between hippocampal CA1 pyramidal neurons and the subiculum ([@bib13]), retinal bipolar cell synapses ([@bib142]), the cerebellar basket cell synapse ([@bib40]), the calyx of Held ([@bib141]), and cerebellar parallel fiber synapse ([@bib214]; but see [@bib137]; [@bib237] for conflicting studies). Syt-7--mediated asynchronous release is substantial after action potential trains, which could allow presynaptic cells to exert sustained impact on postsynaptic activity for hundreds of milliseconds ([@bib151]; [@bib142]).

Facilitation {#s07}
------------

Syt-7 has recently been shown to be required for synaptic facilitation at multiple synapses in the hippocampus and thalamus ([@bib112]). At these synapses, facilitation driven by a single action potential causes a ∼2-fold enhancement of synaptic vesicle release, which decays with a time constant of ∼100 ms. In global Syt-7 KO animals, facilitation was completely abolished. Notably, facilitation could be restored in adult animals in a cell-autonomous fashion by virally driven rescue expression of Syt-7, suggesting that the loss of facilitation was not a result of abnormal development in global Syt-7 KO animals ([@bib112]). Rescue expression of Syt-7 with a mutated Ca^2+^-binding C2A domain did not restore facilitation, showing that Syt-7's high-affinity Ca^2+^ binding is essential for facilitation.

Subsequent studies have revealed a novel function for Syt-7--mediated facilitation. Several synapses in the cerebellum and medial vestibular nucleus display net synaptic depression despite exhibiting prominent Syt-7 expression ([@bib40]; [@bib215]). Interestingly, these synapses share an uncommon trait: in response to repeated stimulation, they depress to the same steady-state response amplitude regardless of the stimulus frequency. It is possible these synapses have a hidden component of facilitation that perfectly counters depression to create a "frequency-invariant" synapse, because use-dependent vesicle depletion (the primary cause of depression) and use-dependent facilitation (driven by Syt-7) both increase with stimulus frequency. Indeed, at the cerebellar Purkinje cell synapse, prominent facilitation was revealed when the initial release probability was decreased by lowering extracellular Ca^2+^, and frequency invariance was lost in Syt-7 KO animals ([@bib215]). Thus, Syt-7 may be responsible for an underappreciated class of synapses that are perfectly able to transmit the rate of presynaptic activity by maintaining constant responses over a wide range of firing frequencies.

Understanding Syt-7 actions {#s08}
---------------------------

The mechanism by which Syt-7 produces either asynchronous release or facilitation remains to be determined. The conventional view is that it does so from the plasma membrane by increasing the probability of fusion of Syt-1--bearing vesicles ([@bib205]; [@bib112]). The structural similarities between Syt-1 and Syt-7 suggest that the two isoforms might use similar mechanisms (discussed in detail in later sections) to drive the fusion of synaptic vesicles with the plasma membrane. Recent studies support the idea that Syt-1 and Syt-7 are equally and independently capable of driving vesicle fusion ([@bib14]).

Synaptic vesicle fusion depends critically on Syt-1's ability to bind anionic lipids in a Ca^2+^-dependent manner ([@bib36]; [@bib113]). Upon binding Ca^2+^, Syt-1 pulls synaptic vesicles closer to the plasma membrane, which may lower the energy barrier for fusion ([@bib35]). Ca^2+^-bound C2 domains can also insert deeply into membranes, inducing curvature that further lowers the energy barrier ([@bib148]; [@bib109]). Insertion into the membrane appears to be especially important, as a point mutation to a membrane-inserting hydrophobic residue completely abolishes Syt-1--mediated synaptic vesicle fusion ([@bib17]; [@bib101]; [@bib164]).

Recently, an author of this review ([@bib112]) proposed a model of synaptic release based solely on the observed membrane-binding properties of Syt-1 and Syt-7 ([@bib28]; [Fig. 3](#fig3){ref-type="fig"}). According to this model, the 40-*k*~B~T energy barrier for fusion ([@bib126]) decreases when presynaptic Ca^2+^ binds to either Syt-1 or Syt-7. The rate constant for fusion is then predicted by the Arrhenius equation. Syt-1's low Ca^2+^ affinity and fast membrane-binding kinetics allow it to quickly bind and unbind from membranes during an action potential, leading to synchronous vesicle fusion. In contrast, Syt-7's high Ca^2+^ affinity and slow binding kinetics keep it bound to membranes in between action potentials, which may lower the energy barrier for fusion and facilitate the action of Syt-1 during subsequent action potentials. A necessary constraint of this model is that Syt-7 is less effective than Syt-1 at lowering the energy barrier, as the model otherwise predicts high rates of sustained fusion in between action potentials. However, even in the absence of Ca^2+^-bound Syt-1, the model predicts that Syt-7 will drive very low rates of fusion for ∼100 ms after an action potential. This could explain Syt-7's role in asynchronous release. Indeed, when Syt-1 is removed from the model, the predicted fusion rates display striking similarities to Syt-7--driven release recorded from Syt-1 KO neurons ([@bib13]).

![**Membrane-binding kinetics of Syt-7 may explain its role in asynchronous release. (A)** The C2 domains of Syt-1 and Syt-7 both bind membranes in a Ca^2+^-dependent manner. However, Syt-7 binds Ca^2+^ with much higher affinity and exhibits far slower unbinding kinetics after Ca^2+^ levels subside. **(B)** Modeled membrane binding of the two isoforms in response to a 100-Hz train of action potentials. Syt-1 rapidly releases from membranes in between action potentials, whereas Syt-7 binding continues to increase during the train. See [@bib111] for modeling parameters. **(C)** For vesicles to fuse with the plasma membrane, they must overcome the energy barrier associated with merging the two lipid bilayers. Syt-1 (and likely Syt-7) lowers the barrier by bringing the two membranes in close apposition and inducing membrane curvature. **(D)** Modeling fusion rates without a contribution from Syt-1 (black line) predicts release rates that display similarities to synaptic responses recorded from Syt-1 KO neurons (adapted with permission from [@bib13]). Syt-7 knockdown profoundly reduced release, indicating that the asynchronous release is driven mostly by Syt-7.](JGP_201711944_Fig3){#fig3}

Until recently, it was unclear whether Syt-7 could simultaneously support both asynchronous release and facilitation. Studies of the role of Syt-7 in asynchronous release were performed using synapses that do not show facilitation ([@bib239]; [@bib13]), whereas studies of facilitation were performed at synapses without prominent asynchronous release ([@bib112]; [@bib215]). Two recent studies examined synapses that possess asynchronous release and facilitation and found that deletion of Syt-7 profoundly impaired both forms of plasticity ([@bib40]; [@bib214]). This supports the hypothesis that a single mechanism underlies the two phenomena ([@bib172]; [@bib219]). Syt-7 likely produces a prolonged increase in the probability of release after an action potential, which can manifest as either a low rate of sustained fusion (asynchronous release) or dramatic increase in subsequent Syt-1--driven fusion (facilitation). It is interesting to speculate whether asynchronous release might be an inevitable consequence of facilitation, or vice versa.

Other mediators of asynchronous release {#s09}
---------------------------------------

Asynchronous release is not completely abolished by the removal of Syt-7 ([@bib13]; [@bib40]; [@bib214]). Thus, it is likely that other presynaptic Ca^2+^ sensors perform functions that partly or completely overlap with Syt-7. Doc2 proteins are likely candidates for such functions ([@bib246]; [@bib245]). Similar to synaptotagmins, Doc2α and Doc2β possess a pair of Ca^2+^-binding C2 domains, but they lack a transmembrane domain ([@bib246]). Doc2 interacts with SNARE proteins and membranes in a Ca^2+^-dependent manner, but with higher Ca^2+^ affinity and slower binding kinetics than Syt-1 ([@bib246]). Although Doc2 is cytoplasmic, upon binding Ca^2+^, it translocates to the plasma membrane and contributes to asynchronous release in cultured hippocampal neurons as well as dense-core vesicle exocytosis from chromaffin cells ([@bib245]; [@bib106]).

A small component of facilitation also persists at Syt-7 KO synapses at the cerebellar parallel fiber synapse ([@bib214]) and calyx of Held ([@bib141]). The remaining facilitation exhibits a decay that is faster than the facilitation driven by Syt-7. Early studies of facilitation at the frog NMJ detected two distinct components of facilitation, termed F~1~ and F~2~ ([@bib147]). These two components of facilitation decayed with time constants roughly equal to facilitation observed in the absence of Syt-7 (F~1~) and facilitation driven by Syt-7 at wild-type synapses (F~2~). Revealing the mechanism behind F~1~ is an important step toward understanding the functional role of this fast form of facilitation in synaptic transmission.

The role of Syt-7 in neuroendocrine cell secretion {#s10}
==================================================

Cell-based, biophysical studies on dynamics of the fusion pore have revealed characteristic effects of Syt-7 on the steps of fusion pore opening and subsequent dilation/expansion ([@bib187]; [@bib253]; [@bib174]). In considering these effects, it is useful to contrast Syt-7's effects on the rate and extent of fusion with the corresponding activities of Syt-1, to highlight unique aspects of Syt-7 function. Both isoforms are present in neurons ([@bib85]; [@bib132]; [@bib217]; [@bib205]) and chromaffin cells ([@bib77]; [@bib185]), and differences in fusion pore dynamics suggest that the interplay of their activities can produce multilayered regulatory control over fusion outcomes. In the discussion below, particular emphasis is placed on the role of Syt-7 in the control of exocytosis in adrenomedullary chromaffin cells.

The fusion pore {#s11}
---------------

Vesicle fusion progresses from a prefusion contact point to the eventual generation of a fusion pore, an aqueous connection between the vesicle interior and cell exterior through which cargos are discharged. One of the important intermediates in this pathway is thought to be "hemifusion," which is operationally defined as lipid mixing without aqueous content mixing ([@bib43]). Studies in reconstituted systems suggest that the prevalence of hemifusion, and the stability of such an intermediate in general, depends on the characteristics of the lipids (intrinsic curvature, liposome size, etc.) and identity of proteins involved in the fusion reaction ([@bib42]; [@bib247]; [@bib128]; [@bib59]; [@bib100]). In chromaffin cells, the hemifused state may actually constitute a regulated step in the transition from vesicle--plasma membrane contact to pore opening, or from pore opening to dynamin-dependent fission ([@bib255]). Whether Syt-1 has a role in these processes besides accelerating the transition from the hemifused state to pore opening is unclear ([@bib128]). However, Syt-7 has features that distinguish it from Syt-1 and suggest it may more effectively stabilize highly curved intermediates along the fusion pathway (see [Fig. 8](#fig8){ref-type="fig"}). The stabilization of such intermediates may delay the transition from hemifusion to pore formation ([@bib255]) and/or pore formation to expansion ([@bib174]). Hemifused intermediates may represent energetically favorable sites for dynamin-dependent fission mechanisms ([@bib138]) which work to counter the tendency for pores to expand ([@bib8]; [@bib255]). This idea is supported by evidence showing an increased likelihood of a "kiss-and-run" form of endocytosis occurring at sites of Syt-7 vesicle fusion ([@bib174]).

Once formed, the fusion pore can be viewed as a narrow channel that enables the outward flux of neurotransmitter molecules. With amperometry, which allows the most sensitive measure of content flux through an open pore, the nascent pore is characterized by a distinctive "prespike foot" ([@bib240]; [@bib48]). The prespike foot consists of small-amplitude current flickers that likely correspond to the trickle of neurotransmitter escaping the pore while it is still narrow ([@bib6]; [@bib259]). The fusion pore may then expand to permit rapid release of the remaining neurotransmitter contents in a burst represented by a large spike in the amperometric trace ([@bib240]; [@bib48]; [@bib186]); alternatively, it may reseal to produce kiss-and-run events in which only a fraction of the vesicle's contents is released ([@bib88]; [@bib231], [@bib232]; [@bib79]). These kiss-and-run events are indicated by stand-alone feet in the amperometric traces ([@bib259]). The narrow angstrom-scale diameter of the fusion pore permits passage of small neurotransmitter molecules and retention of larger peptide cargo molecules ([@bib145]). Therefore, kiss-and-run events provide a mechanism for controlling the quantity and identity of content being released. Many of these concepts, including the structure and possible regulators of fusion pores, are reviewed elegantly by [@bib34].

Amperometric measurements of norepinephrine release from PC12 cells were the first to reveal Syt-dependent effects on control of fusion pore opening and stability ([@bib230], [@bib231],[@bib235]; [@bib19]; [@bib252]). The main effects of overexpressed Syt-7 were an overall increased frequency of fusion events as well as a stabilization of the fusion pore compared with Syt-1 and Syt-9 ([@bib252], [@bib253]). The degree of fusion pore stabilization was correlated with in vitro measurements of synaptotagmin binding to PS-containing lipids. In contrast, there was no evidence for a correlation between the strength of Ca^2+^-independent and -dependent interactions with SNARE proteins syntaxin and SNAP-25 or for the ability of synaptotagmin to facilitate SNARE complex assembly with stabilization of the fusion pore ([@bib252]). It was concluded that isoform-specific differences in interactions with anionic phospholipid effectors may underlie differences in rates of fusion pore transitions ([@bib252]).

Regulation of fusion pore expansion {#s12}
-----------------------------------

In primary chromaffin cells, endogenous synaptotagmin isoforms number two (Syt-1 and -7; [@bib185]) or four (Syt-1, -4, -7, and -9; [@bib150]). However, only Syt-1 and Syt-7 have been identified on dense-core vesicles. Isoform-specific effects on the fusion pore, its expansion, and the concomitant release of cargo proteins are evident in chromaffin cells imaged with conventional or polarized TIRF (pTIRF) microscopy ([@bib7]; [@bib174]). pTIRF microscopy relies on the use of a lipophilic dye (DiI or DiD) that embeds in the membrane with a fixed orientation. Upon fusion, the dye diffuses from the plasma membrane into the vesicle membrane. Alternate excitation by light polarized parallel or perpendicular to the coverslip and detection of the resultant emissions can be used to identify regions of high curvature and deduce membrane geometries associated with pore expansion ([@bib7]).

The stability of localized regions of curvature representing the fused vesicle/plasma membrane domain is substantially enhanced after fusion of Syt-7--bearing vesicles ([Fig. 4](#fig4){ref-type="fig"}; [@bib174]). In contrast, indentations associated with Syt-1 fusion events have a much shorter lifetime, suggesting that they are more likely to collapse into the plasma membrane after fusion ([@bib174]). Accordingly, fluorescent cargos are discharged slowly from vesicles bearing fluorescent Syt-7 ([@bib175]; [@bib23]). These results indicate that Syt-7 stabilizes areas of high membrane curvature during exocytosis in cells, which seems to be in agreement with amperometric measurements of fusion pore stabilization ([@bib253]).

![**Fusion pores of Syt-7--bearing dense-core vesicles are characterized by slow expansion. (A)** Time series of a pHluorin-tagged Syt-7--bearing vesicle undergoing exocytosis with associated changes in DiD-labeled membrane fluorescence (*P/S* and *P+*2*S*). Bar, 960 nm. The cell was periodically perfused with a low-pH (5.5) solution to verify that the fusion pore was still open (note quenching of pHluorin fluorescence at times 6.0 and 21.2 s). **(B--D)** Intensity-versus-time curves for images in A. The dotted black line indicates the fusion frame (time 0). Black bars indicate pH 5.5 wash. A.F.U., arbitrary fluorescence units. **(E)** Simulations based on *P/S* and *P+*2*S* fluorescence emission suggest that the fusion pore is not expanding or is expanding slowly. Modified from [@bib174].](JGP_201711944_Fig4){#fig4}

It should be noted here that the long persistence of fusion-site membrane curvature observed by optical methods represents a much slower process than the transition from prespike foot to burst of neurotransmitter release captured by amperometry recordings, which occurs in a matter of milliseconds ([@bib6]; [@bib2]; [@bib3]). Though both phenomena have been interpreted as expansion of the fusion pore, they are likely to represent sequential kinetic steps in the process of exocytosis, and we propose drawing a distinction between them. A fast initial widening of the fusion pore (\<3 nm; [@bib2]) could allow complete release of small neurotransmitters but may not increase the pore diameter to the extent required for passage of larger peptide cargo. This step would occur too quickly to be resolved by the frame rate of the fluorescence measurements, which is on the order of 10 Hz. A subsequent, more extensive opening, which is the step observed by pTIRF, would permit exit of peptides and larger molecules from the vesicle ([@bib210]; [@bib170]; [@bib145]). This two-step model would be consistent with proposals that the fusion pore acts as a size filter for selective cargo release ([@bib170]; [@bib153]).

Biochemical and optical measurements cited above raise the intriguing possibility that C2 domain lipid interactions regulate structural changes at multiple points during progressive widening of the pore ([@bib231],[@bib235], [@bib232]; [@bib187]). In support of this idea, a chimera of Syt-1, whose C2B domain Ca^2+^-binding loops were exchanged for those of Syt-7, exhibits a higher affinity for anionic phospholipids in the absence of Ca^2+^ and slower dissociation from phospholipids in the presence of Ca^2+^ and, importantly, exerts slowing effects on fusion pore expansion and cargo release kinetics compared with the wild-type protein ([@bib23]). The tight binding of the Syt-7 C2 domains to lipids constituting the fusion pore ([@bib227]) could be a determining factor of pore stabilization, exerting regulatory control over the probabilities for the fusion pore to open, expand, or reseal ([Fig. 5](#fig5){ref-type="fig"}). According to this view, it is possible that the remarkably slow rates of pore expansion of Syt-7 vesicles relative to Syt-1 are linked to the slow dissociation of Syt-7 from target membranes ([@bib107]; [@bib177]; [@bib23]).

![**The exocytotic fate of a Syt-bearing dense-core vesicle. (A)** A vesicle is shown that has yet to fuse or has already fused and undergone endocytosis (i.e., from B to A). Syt-7's N terminus is exposed to the vesicle lumen; the C2 domains are exposed to the cytosol. **(B)** Membrane depolarization and Ca^2+^ influx lead to fusion and fusion pore formation. To trigger entry into this state, the C2A (blue) and C2B (red) might both penetrate the plasma membrane ([@bib15]) or the C2A and C2B might interact with opposing vesicle and plasma membranes ([@bib102]). **(C)** The early fusion pore widens. Continued lipid association of the C2 domains may slow the expansion of the fusion pore ([@bib23]). **(D)** The C2 domains release the plasma membrane as the fusion pore expands.](JGP_201711944_Fig5){#fig5}

TIRF-based measurements of lysosomal exocytosis in mouse embryonic fibroblasts reveal similar inhibitory effects of Syt-7 on fusion pore expansion ([@bib114]). The majority of fusion events from wild-type cells resulted in partial release of lysosome contents. By measuring release of different sized fluorescent dextran molecules, the diameter of the fusion pore during partial release was estimated to be 30 nm, which prevented egress of larger cargoes. However, in Syt-7 KO cells, full release was favored over partial release, and fusion pores were wide enough to permit release of all sizes of dextrans tested. Thus, it was concluded that Syt-7 restricts expansion of the fusion pore during lysosomal exocytosis ([@bib114], [@bib115]). Interestingly, lysosomal exocytosis was triggered by Ca^2+^ even in the absence of Syt-7, suggesting either that Syt-7 regulates lysosomal exocytosis in a fundamentally different way from synaptic vesicle and dense-core vesicle exocytosis, where it couples Ca^2+^ binding to fusion, or that alternative Ca^2+^ sensors are present that take over in the absence of Syt-7 ([@bib114]).

Dynamics of dense-core vesicles {#s13}
-------------------------------

Recent optical imaging studies in bovine chromaffin cells show how the different Ca^2+^ sensitivities of Syt-1 and Syt-7 impact fusion kinetics of their respective vesicle populations ([@bib175]). Small elevations from baseline cytosolic Ca^2+^ levels are generally ineffective at driving fusion of vesicles bearing Syt-1 but much more effective at driving fusion of vesicles bearing Syt-7. This is again consistent with prior in vitro studies, which demonstrated that Syt-7 binds membranes and triggers fusion at far lower Ca^2+^ concentrations compared with Syt-1 ([@bib107]; [@bib236]; [@bib27]). As the Ca^2+^ concentration rises (in cells, ostensibly as a result of membrane depolarization), both populations of vesicles fuse with higher efficiency. These data show that the response times of Syt-1 versus Syt-7 vesicles are finely tuned to levels of intracellular Ca^2+^ in a way that reflects the intrinsic biochemical properties of the synaptotagmin isoforms themselves. From these data emerges a model whereby vesicles that fuse in response to mild depolarization typically release cargos through slowly expanding pores, and vesicles that fuse in response to strong depolarization exhibit a range of pore behaviors, including rapid and more complete release of cargos ([@bib79], [@bib80]; [@bib78]; [@bib174]).

Vesicles bearing fluorescence-tagged Syt-1 or Syt-7 exhibit differences in their preferred fusion locations within cells and are also characterized by different degrees of mobility in their travel to fusion sites ([@bib175]). A fusion location bias might suggest that Syt isoforms are differentially dependent on Ca^2+^ channel subtypes for fusion. Bovine chromaffin cells, in which these studies were performed, express P/Q, N-, and L-type channels, with P/Q channels carrying the majority of the Ca^2+^ current ([@bib83]). Evidence also exists for direct physical coupling between Syt-1 and channel subtypes ([@bib39]; [@bib191]; [@bib241]; [@bib146]). Based on its lower intrinsic affinity for Ca^2+^, one might predict that vesicles bearing Syt-1 are closely positioned to channels to maximize probability of release ([@bib248]). However, multiple in vitro studies demonstrate that Syt-7's Ca^2+^ sensitivity for binding membranes exceeds that of Syt-1 by more than an order of magnitude ([@bib25]; [@bib107]). Thus, vesicles harboring Syt-7 may not be as dependent on close coupling to channels. The clustered (Syt-7 vesicles) versus dispersed (Syt-1 vesicles) fusion locations of chromaffin vesicles may also reflect the requirement for different target SNAREs or preferential binding to different ordered versus disordered lipid phases ([@bib229]) and not channel locations per se. There is not yet convincing evidence that synaptotagmin isoforms require different SNAREs or accessory proteins for fusion. However, given the number of interfaces over which Syt--SNARE interactions are possible ([@bib257], [@bib258]), such differences may play an important role in early or later stages of fusion.

The question of why Syt-bearing vesicles exhibit differences in mobility is an intriguing one ([@bib175]). The most complete biophysical descriptions of vesicle motion, in general, have been provided by Holz, Axelrod, and colleagues ([@bib4], [@bib5]; [@bib56]; [@bib104]). The fundamental observation that such behavior is common ([@bib160], [@bib161]; [@bib89]; [@bib189]; [@bib131]) challenges the assumption that the final moments (within 100 ms) before fusion are characterized by stable protein--protein/lipid interactions. Travel can occur over large distances (tens to even hundreds of nanometers), and travel even increases in the moments before fusion, suggesting that essential steps necessary to prepare a vesicle for fusion, such as priming, do not require a stable interaction between the vesicle and plasma membrane lipids ([@bib63]; [@bib96]; [@bib103]). On a related note, the observation that vesicles have the capacity to fuse almost immediately after entering the evanescent field---termed "newcomers"---raises questions about what constitutes docking from a molecular or even morphological perspective ([@bib175]).

What, then, are the molecular origins of vesicle mobility, and why do they differentially impinge on vesicles bearing different synaptotagmin isoforms? The motions are clearly greater than electrostatic, van der Waals, or hydrogen bond distances ([@bib5]; [@bib56]), and even the length scale over which SNAREs zipper ([@bib208]). One presumes that known modulators of motion, including actin and myosin, are somehow involved ([@bib130]; [@bib133]; [@bib158]; [@bib58]; [@bib24]; [@bib167]; [@bib224]); myosin's activities are modified by Ca^2+^ and ATP ([@bib155]; [@bib181]; [@bib123]). Whether these or additional proteins act to affect vesicle mobility to different degrees, or whether different proteins act to promote or hinder travel independently, are questions that have yet to be answered. The fundamental reason mobility may be greater for some vesicles than others may be a practical one. Motion may allow a vesicle to sample new, unexplored regions of the membrane where fruitful interactions leading to fusion are more likely to exist ([@bib56]). Based on this logic, larger-scale motions are less evident in Syt-7 bearing vesicles because they are somehow shepherded to regions more "favorable" for fusion. A goal for future studies might be to identify what privileges those regions---including their protein and lipid constituents---as exocytotic sites.

Vesicle pools {#s14}
-------------

The studies referenced above demonstrate the influence of Syt-7 activity on the fusion properties of individual vesicles and suggest the type of behavior that would be expected for vesicles regulated solely or predominantly by one synaptotagmin isoform. However, it may not always be true that each vesicle is paired with a particular synaptotagmin isoform that determines its fusion properties. Electrophysiological studies in chromaffin cells have suggested that Syt-1 and Syt-7 activities jointly contribute to regulation of the same vesicle pools ([@bib185]). Upon stimulation, exocytosis measured by capacitance and amperometry occurred in stages, with the initial fast phase corresponding to release from the RRP and a delayed release component from the SRP of vesicles ([@bib197]; [@bib185]). In Syt-1 and Syt-7 double KO cells, both the fast and slow components disappeared, and overall exocytosis was reduced by more than 70%, leaving behind only a very slow secretory component ([@bib185]). Although it would be tempting to attribute release from the RRP to activation by Syt-1 and release from the SRP to activation by Syt-7, the data suggest a more complicated picture involving overlapping regulatory effects. The fast burst of release is eliminated in Syt-1 KO cells, showing that Syt-1 is indeed required for RRP release. However, Syt-7 concurrently modulates release from this subpool of vesicles as shown by a smaller fast burst of release with a quicker time constant in Syt-7 KO cells compared with wild type. Similarly, although Syt-7 is responsible for triggering the slow burst of exocytosis in a Syt-1 KO background, a minor component of the slow burst phase is still observed in Syt-7 KO cells. This suggests that Syt-1 may also contribute to triggering exocytosis from the SRP ([@bib185]). Thus, a complex interplay of competing Syt-1 and Syt-7 activities appears to determine the fate of vesicles in both the RRP and SRP.

Structural and biochemical properties of Syt-7 {#s15}
==============================================

To define the functional properties of Syt-7 and what differentiates those properties from Syt-1 or other isoforms, one should begin by considering the C2 domains that form most of the cytoplasmic region of the protein. Current data suggest that the relative importance of the tandem C2 domains in regulation of exocytosis may differ between Syt-1 and Syt-7. One study addressed this point by comparing exocytosis in wild-type mice, Syt-7 KO mice, and knock-in (KI) mice expressing a mutant in which Ca^2+^ binding to Syt-7 C2B was disrupted ([@bib187]). Dual-capacitance and amperometry measurements indicated that the number of exocytotic events was decreased in the Syt-7 KO but not the Syt-7 KI. However, when Ca^2+^ binding to C2B was disrupted, the fusion pores were prone to closing, yielding an increase in kiss-and-run fusion events indicated by transient increases in membrane capacitance coincident with reduced amplitude amperometric spikes. Thus, C2A activity was deemed necessary and sufficient for fusion pore opening, whereas C2B was additionally required for stabilizing the fusion pore and promoting its expansion ([@bib187]). Although disruption of Ca^2+^ binding to Syt-7 C2A but not C2B prevented rescue of asynchronous release in Syt-1 and Syt-7 double-deficient hippocampal neurons, the opposite was true for rescue of Syt-1--mediated fast, synchronous release ([@bib13]). Thus, the relative importance of the C2 domains are reversed, with Ca^2+^ binding to C2A required for Syt-7--triggered release and Ca^2+^ binding to C2B required for Syt-1--triggered release. In the same study, Syt-7 overexpression reduced the frequency of spontaneous, mini-release in Syt-1 KO neurons ([@bib13]). The ability of Syt-7 to clamp miniature inhibitory postsynaptic currents was disrupted by mutation of Ca^2+^ binding sites in C2A but not C2B, again demonstrating a special importance for the Syt-7 C2A domain.

Comparison of Syt-7 and Syt-1 ion binding {#s16}
-----------------------------------------

Presumably, Syt-7--specific effects on exocytosis arise from unique structural and biochemical characteristics. This is a puzzling problem given the high degree of sequence and structural similarity between conserved domains in Syt-1 and Syt-7, which suggests that subtle structural variations ([Fig. 6](#fig6){ref-type="fig"}) coalesce to produce substantial functional differences ([@bib64]; [@bib227]; [@bib23]). Perhaps the most important biochemical signature of Syt-7 that sets it apart from the other synaptotagmin isoforms is its extreme Ca^2+^ sensitivity. Syt-7 stimulation of SNARE-mediated liposome fusion occurs with a 400-fold higher sensitivity to Ca^2+^ than that of Syt-1 ([@bib25]).

![**Conservation of domain structures within the C2A and C2B domains of Syt-1 and Syt-7. (A)** Superimposed experimental structures of C2A domains of Syt-7 (PDB accession no. [6ANJ](6ANJ){#dblnk44bd2562-6b09-c8d4-833c-baaf19b8b388}) and Syt-1 (PDB accession no. [1BYN](1BYN){#dblnka1324ac3-270f-b4a2-3782-94e04abecf1b}, first frame) aligned using MultiSeq ([@bib190]; [@bib180]; [@bib227]). The proteins are shown in cartoon format (wider sheets for Syt-1 and narrower sheets for Syt-7) and are colored according to the *Q*~res~ values, which measure the backbone structural similarity of each residue between the two aligned structures (blue for high similarity and red for low similarity). The backbone RMSD value is 1.4 Å. The polybasic region (PBR) is highlighted in yellow. The Ca^2+^-binding loops (CBL1--3) and helix A (HA) are labeled. **(B and C)** Ca^2+^-binding loops in Syt-7 (B) and Syt-1 (C) C2A domain experimental structures. The proteins are illustrated in cartoon format as green for Syt-7 and gray for Syt-1. The residues that coordinate the Ca^2+^ ions (yellow spheres) are shown as sticks (O, red; C, cyan). **(D--F)** are similar to A--C, but for the C2B domains of Syt-7 (PDB accession no. [3N5A](3N5A){#dblnkd814ca64-dadf-8e0a-edf4-31adfec6e3d2}) and Syt-1 (PDB accession no. [1TJX](1TJX){#dblnkf534f47f-8e89-7f-9efc-b12d6e8b2ca6}; [@bib41]; [@bib244]). The backbone RMSD value is 0.9 Å. Highlighted in yellow are the two polybasic regions PBR~1~ and PBR~2~; PBR~1~ maps to β-strand 4 and aligns to the PBR on the C2A domains. Helix B (HB) is presented in Syt-1 and not in Syt-7. The red arrow indicates Ser362, which is present in Syt-7 and helps to coordinate the outermost Ca^2+^ but is missing in Syt-1.](JGP_201711944_Fig6){#fig6}

The Ca^2+^-sensing ability of the synaptotagmins arises from their C2A and C2B domains, which are members of the protein kinase C family of C2 domains known for binding intracellular membranes in a Ca^2+^-dependent manner ([@bib156]). Each C2 domain consists of an eight-stranded β sandwich in an oblong shape ∼4 nm long and 2 nm wide, with flexible loops projecting from each end ([Fig. 6, A and D](#fig6){ref-type="fig"}; [@bib51]). Three Ca^2+^-binding loops located on one end of each C2 domain (CBL1-3 in [Fig. 7](#fig7){ref-type="fig"}) contain five conserved aspartate residues that coordinate Ca^2+^ ions ([Fig. 6, B, C, E, and F](#fig6){ref-type="fig"}; and [Fig. 7](#fig7){ref-type="fig"}; [@bib207]). The much higher Ca^2+^ sensitivity of Syt-7 relative to Syt-1 is surprising considering their high degree of structural similarity. The Syt-7 C2A and C2B domains are essentially superimposable on the corresponding domains of Syt-1, with overlap observed for even many of the individual amino acid side-chain orientations ([@bib244]; [@bib227]). Furthermore, the Ca^2+^ affinities of the isolated Syt-1 and Syt-7 C2A domains in solution are nearly identical, even though the Syt-7 C2A domain binds PS-containing membranes at ∼50-fold lower Ca^2+^ concentrations ([@bib206]; [@bib152]). This suggests that the enhanced Ca^2+^ sensitivity arises from stronger membrane binding by the Ca^2+^-loaded state of Syt-7 relative to Syt-1 ([@bib28]; [@bib227]). In alignments of the respective C2A and C2B domain structures, the most noticeable difference is the presence of a C-terminal α-helix on Syt-1 C2B (the HB helix) that is absent from Syt-7 C2B ([@bib68]; [@bib41]; [@bib244]). Subtle differences also exist in the positioning of residues in the HA helices and loops in both domains, although the latter may be attributable to crystal contacts ([Fig. 6, A and D](#fig6){ref-type="fig"}).

![**Amino acid sequence comparison of Syt-7 and Syt-1.** The canonical rat sequences (UniProt accession nos. Q62747-1 and P21707-1) were aligned along with the other rat synaptotagmin isoforms plus human Syt-1 and Syt-7 using Clustal Omega ([@bib193]). The human sequences (not depicted) are identical within the cytoplasmic region except for positions 66 (Ser instead of Gly), 156 (Ile instead of Val), and 325 (Met instead of Lys) of Syt-7. Transmembrane (TM) and C2 domain regions are highlighted ([@bib140]). Lys/Arg (blue) and Asp/Glu (red) residues in the TM-C2A linker region are highlighted ([@bib129]). The Ca^2+^- and membrane-binding loops (CBL) are boxed in red, with residues in bold whose side chains coordinate Ca^2+^. Polybasic regions boxed in blue correspond to those indicated in [Fig. 6 (A and D)](#fig6){ref-type="fig"}. S103 (starred) represents a Syt-7 phosphorylation site ([@bib242]).](JGP_201711944_Fig7){#fig7}

Still, even small differences in positioning, dynamics, or flexibility of the loops may endow the isoforms with different divalent ion binding characteristics. Although the solution structure of the Syt-1 C2B domain contains two Ca^2+^ ions in the Ca^2+^-binding pocket, the C2B domain from Syt-7 as well as C2A domains from both proteins bind three Ca^2+^ each ([@bib190]; [@bib68]; [@bib244]; [@bib227]). The Syt-1 C2B domain has been crystallized with three Ca^2+^ at extremely high Ca^2+^ concentrations (\>50 mM) or when bound to a soluble form of PS, suggesting that the membrane-bound state may involve three Ca^2+^ ([@bib41]; [@bib105]). The greater Ca^2+^ binding ability of the Syt-7 C2B domain may arise from the presence of a Ser side chain (Ser362) that is not present in most Syt C2B domains but is conserved among Ca^2+^-sensitive Syt C2A domains ([@bib251]; [@bib68]; [Fig. 6, D and E](#fig6){ref-type="fig"}). The synaptotagmin isoforms also exhibit different divalent ion selectivities, with Syt-7 but not Syt-1 capable of binding liposomes containing 15% PS and stimulating SNARE-mediated membrane fusion with the larger Sr^2+^ and Ba^2+^ ions as well as Ca^2+^ ([@bib25]). The ability to bind these larger cations appears to be a property of the Syt-7 metal-binding loops, as an engineered chimera of Syt-1 containing loops from Syt-7 efficiently coupled Sr^2+^ binding to membrane fusion in vitro and to exocytosis in mouse hippocampal neurons ([@bib64]).

Ca^2+^ binding to the C2 domains' loop regions neutralizes the negative charge of the aspartic acid residues and promotes penetration of the Ca^2+^ binding loops into anionic lipid bilayers ([@bib251]; [@bib216]; [@bib101]; [@bib108]). The synaptotagmin isoforms have been grouped according to the speed with which they dissociate from PS-containing liposomes after chelation of Ca^2+^ by EDTA, with Syt-7 showing by far the slowest dissociation kinetics ([@bib107]). Electron paramagnetic resonance measurements indicate that the Syt-7 C2A domain may insert more deeply into lipid bilayers than Syt-1 C2A ([@bib162]). Biochemical experiments and atomistic molecular dynamics simulations demonstrate a large hydrophobic component to C2A lipid interactions that plays a role in increasing binding stability. A significant contribution to the energetic stabilization arises from the phenylalanine residues at the tips of Ca^2+^ binding loops 1 and 3 including Phe167, which corresponds to a methionine in Syt-1 ([@bib28]; [@bib47]; [@bib223]). Recently, a second important residue was also identified in the Syt-7 C2A binding loop: Arg231, whose forked guanidino group binds more efficiently to PS than the lysine found at the corresponding position in Syt-1. Combined mutation of both Arg231 and Phe167 in the C2A domain of Syt-7 significantly weakens its lipid binding, although the mutant Syt-7 C2A domain still binds membranes much more strongly than Syt-1 ([@bib227]). The same study also reported that the Syt-7 C2B domain binds more tightly to membranes than its counterpart in Syt-1, consistent with molecular modeling results that showed more contacts with PS lipids for both C2 domains of Syt-7 compared with their counterparts in Syt-1 ([@bib223]; [@bib227]).

Further defining the molecular determinants of Syt-7's stronger binding and slower dissociation from membranes may be relevant for understanding the mechanisms through which Syt-7 regulates various stages of exocytosis. Indeed, limited mutations that slightly enhance Syt-1's membrane affinity have outsized effects on fusion pore formation, pore expansion rates, and even the likelihood of fusion ([@bib23]). Isoform-specific effects of synaptotagmins on exocytosis may even be attributable to differentiable, biophysical properties of their respective C2A and C2B domains ([@bib204], [@bib206]; [@bib203]; [@bib107], [@bib109]; [@bib187]; [@bib13]; [@bib227]). For example, the Ca^2+^-saturated Syt-7 C2A domain binds membranes with or without PIP2 much more strongly than does Syt-1 C2A, and its affinity is comparable to that of Syt-7 C2B in the presence of PIP2 ([@bib227]). In contrast, the C2B domain of Syt-1, in the presence of PIP2 (and Ca^2+^), binds membranes more strongly than the Syt-1 C2A domain ([@bib227]). These differences in strength of membrane binding of the Syt-1 versus Syt-7 C2A/B appear to correlate with their relative functional importance during exocytosis ([@bib187]; [@bib13]). On the other hand, the functional importance of the Syt-1 C2A domain may be greater than originally believed; a charge-conserving mutation that blocks Ca^2+^ binding in this domain decreased the efficiency of synchronous neurotransmitter release by ∼80% ([@bib199]).

Aside from the C2 domains, synaptotagmins exhibit substantial variation in amino acid sequence in the region between the transmembrane domain and the C2A domain. In Syt-1, the N- and C-terminal portions of this linker region are rich in basic and acidic residues, respectively, and have been suggested to comprise an electrostatic zipper that contributes to regulation of fusion pore opening and protein--lipid binding ([@bib129]; [@bib140]; [@bib67]). The sequence of the canonical Syt-7 linker region displays a somewhat similar electrostatic pattern, although the overall sequence conservation is low ([Fig. 7](#fig7){ref-type="fig"}). The role of this region of Syt-7 is relatively unexplored, other than its role in alternative splicing as discussed above.

Syt-7 protein effectors {#s17}
-----------------------

Multiple models explain how synaptotagmin regulates exocytosis, but most agree that regulation involves interactions with anionic phospholipids ([@bib198]; [@bib165], [@bib166]), probably in conjunction with SNAREs ([@bib36]; [@bib44]; [@bib163]; [@bib109]; [@bib202]; [@bib256], [@bib257], [@bib258]; [@bib29]). The t-SNAREs syntaxin and SNAP-23/25, together with the vesicle v-SNARE synaptobrevin/VAMP, constitute the minimal complement of proteins required for vesicle fusion in vitro ([@bib195],[@bib196]; [@bib238]; [@bib213]). Inclusion of the soluble C2AB fragment of synaptotagmin in an in vitro liposome fusion assay dramatically increases the rate and extent of fusion in the presence of Ca^2+^ ([@bib213]; [@bib81]). Syt-7 stimulates SNARE-driven membrane fusion with half-maximum activity at 0.30 µM Ca^2+^, a Ca^2+^ sensitivity more than 400 times higher than that of Syt-1, and the highest in the Syt family ([@bib25]). Synaptotagmin may exist in dynamic equilibrium between SNARE-bound and unbound states; complexin binding to the SNARE complex might enhance and stabilize the SNARE-bound state of synaptotagmin ([@bib31]; [@bib136]). It should be noted, however, that complexin has also been characterized as a fusion clamp, preventing SNARE zippering without the energy imparted from Syt-Ca^2+^/membrane binding ([@bib86]; [@bib125]).

Synaptotagmin--SNARE interactions---and in particular, Syt-1--SNARE interactions---have been implicated in both clamping spontaneous release and triggering fusion in response to Ca^2+^ ([@bib81]; [@bib144]; [@bib110]; [@bib121]; [@bib16]). Several different interaction surfaces have been identified ([@bib257], [@bib258]) with more than one study pinpointing the lysine-rich polybasic patch on the β-4 strand of C2B in binding the syntaxin/SNAP-25 heterodimer in a Ca^2+^-independent manner ([@bib15]; [@bib19]; [@bib178]). We note that these interactions are highly sensitive to ionic strength, and the physiological significance of these interactions has been the subject of some debate ([@bib166]). One possibility is that multiple modes of weak Syt--SNARE interaction may be tuned for rapid reversibility in the crowded and dynamic environment of a fusion pore.

A comparative analysis of Syt-1 and Syt-7 SNARE binding detected no substantial differences in overall SNARE-binding affinity ([@bib179]); however, sequence differences could have subtle regulatory effects on Syt--SNARE interactions. For example, the Syt-7 C2A domain binds syntaxin in vitro at low micromolar Ca^2+^ concentrations, whereas by comparison Syt-1 C2A requires 200 µM Ca^2+^ ([@bib132]). Interestingly, three Ca^2+^-independent interfaces recently identified in a crystal structure of Syt-1 and SNARE proteins are not conserved in Syt-7 ([@bib257]). Thus, the relevance of these Syt-1/SNARE complexes to Syt-7 function is not yet clear. However, given the multitude of interfaces identified between Syt-1 C2AB and SNAREs ([@bib257], [@bib258]), it is possible that other contacts between Syt-7 and SNARE proteins regulate its isoform-specific functions in the successive steps of docking, priming, fusion, and pore expansion.

Syt-7 functions in processes such as insulin secretion that use the common SNARE isoforms syntaxin-1a, VAMP2, and SNAP-25 ([@bib82]); however, Syt-7 also interacts with SNAP-23. A specific interaction between SNAP-23 and Syt-7 was identified that contributes to docking of Syt-7--containing vesicles ([@bib45]). When SNAP-23 was substituted in place of SNAP-25 in glutamatergic hippocampal neurons, activities associated with Syt-7--mediated fusion were enhanced, including spontaneous release events. The number of spontaneous release events was increased further upon Syt-7 deletion, signifying that Syt-7 clamps release in the absence of stimulation but overall is a leakier Ca^2+^ sensor than Syt-1. In contrast, Syt-7 KO in the presence of SNAP-25 had little effect on exocytosis. It was concluded that Syt-7 pairs with SNAP-23 and Syt-1 pairs with SNAP-25, and that the specific Syt/SNAP pairing determines fusion kinetics and fidelity ([@bib237]). Optical measurements using pHluorin-tagged synaptotagmins indicated the presence of Syt-1 on vesicles undergoing Syt-7/SNAP-23--mediated fusion, which suggests that, at least in some cases, Syt-7 may not act as the exclusive Ca^2+^ sensor for fusion events but instead may alter the fusion properties of Syt-1--containing vesicles.

It has also been reported that synaptotagmins, especially Syt-7, undergo Ca^2+^ dependent homo- and hetero-oligomerization mediated by their C2 domains ([@bib73],[@bib74]; [@bib75]). Oligomerization of Syt-1 has long been a subject of debate, with some studies indicating self-association and others suggesting the interactions are mediated by other factors ([@bib57]; [@bib216]). An author of this review has provided evidence against direct oligomerization of Syt-7 C2 domains ([@bib28]; [@bib220]). Recently, Syt-1 has been observed to form ring-shaped oligomers via cryo-EM, mediated by anionic lipids or polyanionic solutes, the latter of which produces rings that are insensitive to Ca^2+^ ([@bib233], [@bib234]). Ring formation is conserved among synaptotagmin isoforms including Syt-7, which forms them somewhat more potently than Syt-1 in the presence of anionic membranes ([@bib249]). If synaptotagmins oligomerize in vivo, either directly or indirectly, these structures could serve to regulate steps in the fusion process, and hetero-oligomerization of different synaptotagmin isoforms could provide a means for suppressing or enhancing each other's activities ([@bib27]). However, such rings have not yet been observed in vivo, and the role of synaptotagmin oligomerization in the context of exocytosis is currently unclear.

Syt-7--lipid interactions {#s18}
-------------------------

The interactions between synaptotagmin C2 domains and anionic phospholipids play crucial roles in Ca^2+^-triggered fusion. This is a property that Syt-1 and Syt-7 share, suggesting that the two proteins' membrane interactions may have similar functions in the mechanism of Syt/SNARE/Ca^2+^-triggered membrane fusion. Syt-1 C2A and C2B domains both bind anionic lipids such as PS in a Ca^2+^-dependent manner, mainly via interactions with the Ca^2+^-binding pocket ([@bib251]; [@bib157]; [@bib216]; [@bib169]), and Syt-7 does the same, albeit with greater Ca^2+^ sensitivity owing to stronger hydrophobic lipid interactions ([@bib206]; [@bib28]; [@bib220]; [@bib227]). The C2B domains bind PIP2 at a polybasic region centered on the β-4 strand (PBR1 in [Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}) in a manner that is Ca^2+^ independent but enhanced by Ca^2+^ ([@bib212]; [@bib108]; [@bib171]; [@bib227]). The Syt-7 C2B domain has a robust sensitivity toward PIP2 in vitro ([@bib227]), even though it contains a Lys-to-Glu substitution at position E318 in the β-4 polybasic region ([Fig. 7](#fig7){ref-type="fig"}). Liposome fusion assays are commonly conducted with lipid membranes containing a mixture of PS and phosphatidylcholine, with or without PIP2. Omission of PS and PIP2 from the liposomes results in inability of synaptotagmin to stimulate membrane fusion, indicating anionic lipids to be a critical cofactor for synaptotagmin activity ([@bib25]; [@bib124]). Upon Ca^2+^ binding to the C2A and C2B domains, they penetrate into the lipid bilayer ([@bib17]; [@bib71]; [@bib182]; [@bib162]). This allows synaptotagmin to bend and deform membranes, as indicated by tubulation of liposomes initiated by the Syt-1 C2B or C2AB domain ([@bib148]). The ability of Syt-1 to bend membranes and generate positive curvature is suggested to be an essential part of the mechanism used to stimulate membrane fusion, as tubulation-defective mutants preferentially induced fusion of high-curvature vesicles in vitro ([@bib109]). Membrane penetration by the synaptotagmin C2 domains and generation of positive curvature may help to overcome an energy barrier along the pathway to hemifusion and/or fusion, e.g., by stabilizing a highly curved intermediate state ([Fig. 8](#fig8){ref-type="fig"}).

![**Structural model for Syt stabilization of fusion pores. (A)** Hypothesized relative orientation of C2A and C2B, illustrated from a composite of Syt-7 C2A (PDB accession no. [2D8K](2D8K){#dblnk2dc4b022-210d-6a41-1140-629acb0ab3a3}) and C2B ([@bib244]) structures. Synaptotagmin C2A and C2B domains orient randomly relative to each other in solution ([@bib46]), but catalysis of fusion is most efficient when the two domains point their CBLs (pink and purple; Ca^2+^ ions yellow) in the same direction ([@bib16]), suggesting that the transition state involves the membrane-bound protein in an orientation similar to that shown here. Left: Because the C-terminal residues of the C2A domain and N-terminal residues of the C2B domain are connected by the short C2AB flexible linker, the polybasic β-4 strands orient in opposite directions, in the same way that two people standing face-to-face point their left arms in opposite directions (dark blue spheres: K183, K184, H185, K186 on C2A and K315, R316, K319, K320, K321 on C2B). A second basic cluster on C2B may also contribute to bridging as previously shown for Syt-1 ([@bib243]; light blue spheres: R390 and R392). Right: Same views shown as potential maps, calculated using APBS-PDB2PQR (blue: +50 mV; red: −50 mV equipotential contours, assuming 0.15 M KCl, pH 7.4; [@bib20]; [@bib61]). **(B)** Proposed locations of C2 domains during stabilization of a narrow, high-curvature fusion pore. Here the CBLs insert into the fusion pore neck and stabilize positive curvature in the plane of the pore ring, whereas the polybasic regions interact with anionic lipids on the opposing vesicle and plasma membrane surfaces. The prefusion spacing between vesicle and plasma membranes is roughly ∼2--3 Å, approximately the width of a C2 domain ([@bib59]).](JGP_201711944_Fig8){#fig8}

Another shared property of Syt-1 and Syt-7 C2 domains is their ability to bridge between membrane bilayers and induce aggregation of liposomes in vitro. The C2AB tandem and isolated C2B domain of Syt-1 induce liposome clustering ([@bib9]; [@bib110]; [@bib188]), and the C2A domain of Syt-7 was recently reported to do the same ([@bib94]; [@bib227]). The liposome aggregation effect has complicated the study of Syt-mediated curvature generation in vitro and led to questions about the importance of membrane bridging in synaptotagmin function. Syt-1 C2AB tandem domains can exhibit a wide range of orientations with respect to each other, both in solution and when bound to liposome membranes, including a bridging conformation in which the Ca^2+^-binding loops of C2A and C2B point in opposite directions ([@bib102]; [@bib46]; [@bib188]). Binding to PIP2/syntaxin-1 clusters via the β-4 polybasic region in Syt-1 C2B enhances bridging, as the Ca^2+^-binding loops insert in trans into PS-containing membranes ([@bib105]). A second basic cluster comprising Arg398 and Arg399 (PBR2 in [Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}) also contributes to liposome bridging by Syt-1 C2B ([@bib243]; [@bib105]); however, these residues have also been implicated in protein--protein interactions, and how the interactions balance in vivo is not yet clear ([@bib81]; [@bib110]; [@bib257]).

Central to the bridging question is how the two C2 domains work together, including their relative orientation when bound to membranes. For Syt-1, cis and trans membrane binding exist in a delicate balance, in which relative accessibility of target membranes plays a major role ([@bib222]). Both fluorescence of insertion-dependent dyes and electron paramagnetic resonance depth measurements have been used to show that Syt-1 C2A and C2B insert more deeply into liposome membranes when present as a tandem, relative to the individual domains in isolation ([@bib17]; [@bib101]). These results suggest that the two domains of Syt-1 cooperate to bind and insert into their target membranes, a finding also reported based on force measurements ([@bib209]). However, the effect may be different for Syt-7; lateral diffusion measurements of Syt-7 C2A, C2B, and C2AB domains on supported lipid bilayers were consistent with independent membrane interactions of the two domains, indicating the absence of substantial intermolecular contacts of C2A with C2B ([@bib220]). Liposome binding measurements from the same study further revealed lack of cooperativity in binding and dissociation of Syt-7 from phospholipid membranes. In principle, cooperativity between Syt-7 C2 domains may be unnecessary because of their strong membrane affinity; in Syt-1, interdomain cooperativity could promote rapid and efficient coinsertion despite the relatively modest membrane affinity of its C2A domain. One recent study probed the relative orientation of the two C2 domains in Syt-1 during membrane binding and exocytosis by systematically replacing the C2A-C2B linker with polyproline helices of varying lengths, each constraining the C2A and C2B domains in a particular relative orientation. Results both in vitro and in neurons showed a clear periodicity, indicating that fusion is most efficient when the two domains point their Ca^2+^-binding loops in the same direction ([@bib16]). Although the Ca^2+^-binding loops represent the primary site of membrane interaction, a full picture of synaptotagmin membrane binding requires consideration of the polybasic regions as well as the Ca^2+^-binding loops on both domains.

Model for fusion pore stabilization {#s19}
-----------------------------------

Collectively, the bridging, curvature, and coinsertion data support a structural model in which Syt--lipid interactions stabilize fusion pores by simultaneously inducing positive curvature in the ring of the pore via insertion of the Ca^2+^-binding loops and bridging between the secretory vesicle and plasma membrane in the orthogonal dimension via polybasic regions on both C2 domains ([Fig. 8](#fig8){ref-type="fig"}). This model is similar to the transition state in a previous structural hypothesis of synaptotagmin function ([@bib148]), with the added observation that the polybasic regions of the two domains should be accessible to bind opposing membrane surfaces when their Ca^2+^-binding loops point in the same direction ([Fig. 8 A](#fig8){ref-type="fig"}). Presumably, the β-4 region of C2B (PBR1 in [Fig. 6](#fig6){ref-type="fig"}) orients toward the plasma membrane and binds PIP2, whereas the polybasic region of C2A orients toward the vesicle. Although the polybasic region of synaptotagmin C2A domains is not particularly selective for PIP2 binding because of the presence of a glutamate residue at a key position ([@bib90]), it is nevertheless present in Syt-1 as a region of positive surface charge density and has a greater surface potential in Syt-7 ([@bib47]). The model in [Fig. 8](#fig8){ref-type="fig"} allows for both the Ca^2+^-binding loops and polybasic regions of C2A and C2B to interact with membranes simultaneously and further predicts that fusion pore stabilization should depend on lipid binding via combined effects of all of these interactions.

It was recently shown that fusion of large dense-core vesicles in chromaffin cells and β-cells, two populations that use Syt-7, proceeds via a hemifused intermediate state ([@bib255]). The orientation shown in [Fig. 8](#fig8){ref-type="fig"} could conceivably stabilize higher-energy states involved in formation of the hemifused intermediate and/or conversion of the hemifused intermediate to the fully fused state along with other SNARE fusion machinery proteins. Although [Fig. 8](#fig8){ref-type="fig"} omits SNARE complexes and other accessory proteins for clarity, SNARE proteins are well known to form the core of the fusion machinery ([@bib202]). Proper SNARE assembly is required for fusion, and synaptotagmin was unable to rescue fusion in vitro from a docked state formed by mutant SNARE complexes incapable of complete zippering ([@bib100]). Our model is also not intended to reflect stoichiometry of synaptotagmin or SNARE complexes in the fusion pore, which has been a subject of active investigation ([@bib154]). It is possible that Syt C2AB domains may interact with SNAREs or other proteins during fusion pore stabilization ([@bib54]; [@bib81]). Syt--SNARE interactions are also reported to be associated with clamping fusion before Ca^2+^ entry ([@bib81]; [@bib258]) and/or accelerating postfusion pore expansion ([@bib144]).

The orientation shown in [Fig. 8](#fig8){ref-type="fig"} may represent a high-energy intermediate or transition state and does not specify the trajectory by which this orientation is reached upon Ca^2+^ entry. One possibility is that upon Ca^2+^ entry, the two C2 domains initially interact with whatever membrane is closest, and then are funneled together to the nascent fusion pore neck. (We note that in the crystal structure of the "primed" Syt/SNARE/complexin complex, the Ca^2+^-binding loops of the C2B domain at the tripartite interface orient outward toward the SNARE N termini, an orientation that would place them readily accessible to Ca^2+^ signals \[[@bib258]\].) After initial rapid fusion is a phase of fusion pore expansion, which is also accelerated by synaptotagmin in a Ca^2+^-dependent manner; the rate of expansion is much greater for Syt-1 vesicles than for Syt-7 vesicles ([@bib174]). For Syt-1, rapid fusion pore expansion appears to involve interaction of the C2 domains with both SNARE proteins and membranes ([@bib144]). Chimeras between Syt-1 and Syt-7 exhibit intermediate rates of fusion pore expansion ([@bib23]); the intermolecular interactions responsible for this effect are not yet clear.

Conclusion and future directions {#s20}
================================

Syt-7 was originally identified as a Ca^2+^ sensor for lysosomal exocytosis, but the repertoire of known Syt-7 activities has since expanded to include roles in secretion from many different cell types ([Table 1](#tbl1){ref-type="table"}). Sometimes Syt-7 acts as the principal Ca^2+^ sensor, such as in glucagon secretion from pancreatic α-cells, but for the most part Syt-7 acts in concert with other, faster synaptotagmin isoforms such as Syt-1 to give rise to nuanced secretory outputs in response to different strengths and rates of stimulation, most notably in chromaffin cells and presynaptic axon terminals of the central nervous system. Biophysical studies have shown that Syt-7 exerts differential control over fusion pore opening and expansion, with stabilization of curved membrane structures such as the fusion pore being a hallmark of Syt-7 activity. The high Ca^2+^ sensitivity of Syt-7 and the slow dissociation of its C2 domains after penetration into phospholipid bilayers are just two of its well-established biochemical features. Such features are likely to play a role in the mechanisms Syt-7 uses to exert specialized control over exocytosis dynamics, ultimately enabling modulation of the type, rate, and extent of cargo release in a stimulus- and context-dependent manner. Syt-7 also interacts with many different effector molecules, often through the same structural motifs on the C2A and C2B domains. The overlapping nature of these binding interactions suggests that some may be mutually exclusive. Thus, Syt-7 may participate in a stepwise series of interactions with different partners along the trajectory from vesicle docking, to priming, to fusion pore opening, to fusion pore expansion. The timing of the interactions with different effectors, as well as the mechanistic roles they play in regulating exocytosis dynamics, requires further investigation.

Despite the significant progress made, questions remain about Syt-7's mechanism of action. For example, when do C2 domains insert into the membrane and when are they released relative to fusion pore opening and expansion? Do C2A and C2B domains both penetrate the same membrane, or do they bridge vesicle and plasma membranes? How do C2A and C2B engage their respective effectors, and as mentioned above, do interaction modes change to regulate docking, priming, fusion pore opening, or fusion pore expansion? The ability to start addressing these questions will likely require structural studies of Syt-7 in complex with components of the SNARE apparatus and/or lipid bilayers.

It is also not yet completely understood how the modest sequence and structural differences in the C2 domains of Syt-7 compared with other synaptotagmin isoforms give rise to such substantial differences in fusion pore dynamics. Structural data show highly overlapping folds and positioning of Ca^2+^ ligands comparing Syt-7 with Syt-1, which offers few clues as to the molecular origin of their biochemical and functional differences. It could be that Syt-1 and Syt-7, though highly similar in structure, exhibit important dynamical differences such as specific intra- and/or interdomain conformational changes that regulate biochemical and functional activities, and we suggest that future studies explore this possibility. Analysis of chimeras containing Syt-7 structural elements grafted onto another synaptotagmin isoform or vice versa may also continue to be useful in teasing apart structure--function relationships.

Several apparent discrepancies regarding Syt-7 function remain incompletely resolved, namely: does endogenous Syt-7 exert its regulatory effects from the vesicle or the plasma membrane, and does it regulate individual fusion events independently or in concert with other isoforms, for example by clamping or otherwise modulating fusion kinetics of Syt-1--containing vesicles? These questions point to the larger issue of whether Syt-7 operates via a common mechanism in all cases. The possibilities described above are not necessarily mutually exclusive. Given the large number of cell types in which Syt-7 is expressed and the multitude of fusion processes in which it participates, it would not be entirely surprising to encounter different Syt-7 trafficking patterns, molecular interaction partners, and splice variants in different contexts that alter, in some way, its mode of action. It is possible that Syt-7's versatility in regulating exocytosis dynamics in such a wide array of settings may be paralleled by changes in localization and mode of action that are context dependent.
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